Cargando…
Methylglyoxal products in pre-symptomatic type 1 diabetes
INTRODUCTION: Progression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease. Monitoring products of altered metabolism is a promising tool for determining the risk of type 1 diabetes progression and to supplement existing pr...
Autores principales: | Shuck, Sarah C., Achenbach, Peter, Roep, Bart O., Termini, John S., Hernandez-Castillo, Carlos, Winkler, Christiane, Weiss, Andreas, Ziegler, Anette-Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892703/ https://www.ncbi.nlm.nih.gov/pubmed/36742390 http://dx.doi.org/10.3389/fendo.2023.1108910 |
Ejemplares similares
-
DJ‐1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons
por: Mazza, Melissa Conti, et al.
Publicado: (2022) -
Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study
por: Raab, Jennifer, et al.
Publicado: (2016) -
Methylglyoxal
and Its Adducts: Induction, Repair,
and Association with Disease
por: Lai, Seigmund Wai Tsuen, et al.
Publicado: (2022) -
Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot’s Print
por: Zirpel, Henner, et al.
Publicado: (2021) -
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]
por: Hummel, Sandra, et al.
Publicado: (2023)